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The reason of high mortality in patients with chronic kidney disease (CKD) is cardiovascular disease and arterial calciﬁcation has
been accepted as an additive factor on this status. In this report we described vascular and cardiac valvular calciﬁcations in an
adolescent on CAPD.
1.Introduction
Cardiovascular disease (CVD) is the most common cause of
death in adult and pediatric patients with CKD [1]. It was
determined that cardiac deaths in children and in young
adults in whom end-stage renal disease developed during
childhood were approximately 1000 times more frequent
than in the general pediatric population [2]. Vascular
changes were indicated in pediatric patients with dialysis and
also in predialysis CKD stages 2–4 [3–6]. These functional
and structural vascular abnormalities and arterial calciﬁca-
tions contribute to high cardiac mortality.
In this report, we described the vascular and cardiac
valvular calciﬁcations in an adolescent on CAPD.
2.Case
A 17-year-old boy on CAPD with 4 exchanges per day
(1000mL/body surface area, 2 times 1.36% and 2 times
2.27% glucose solution) for 87 months was admitted to the
hospital with severe bone pain and fatigue. Erythropoietin,
iron, antihypertensive drugs, calcitriol, and calcium contain-
ing phosphate binder had been administrated but the patient
was incompatible with his medication. He has been followed
byanothercenterforlast2yearsunregularly.Hewaspaleand
growth retarded. Physical examination revealed tachycardia,
tachypnea, hypertension, and edema. Laboratory ﬁndings
were determined as follows: hemoglobin 5.4g/dL, hema-
tocrit 22%, serum urea 382mg/dL, creatinine 9.8mg/dL,
albumin 3.1g/dL, calcium 10.6mg/dL, inorganic phospho-
rus 8.6mg/dL, calcium-phosphorus product 91.1mg2/dL2,
iPTH 589pg/mL (normal 9.5–75), and CRP 5.6mg/dL
(normal0–0.8).Radiologicexaminationhasbeenperformed
owing to severe pain on wrists and ankles. In addition to
osteopenic appearance vessel wall calciﬁcations were noticed
in the radial, ulnar, posterior tibial, anterior tibial, and iliac
arteries on radiography (Figures 1, 2,a n d3). Computed
tomography revealed calciﬁcations in the mitral valve,
coronary artery, aorta, splenic, and iliac arteries (Figure 4).
He was transferred to hemodialysis because of ultraﬁl-
tration failure. Medical treatment was rearranged according
to his clinical and laboratory ﬁndings. Calcium containing
phosphate binder was changed to calcium-free phosphate
binders. His complains subsided and serum phosphorous
level decreased gradually.
3. Discussion
It was reported that cardiovascular mortality rate is high in
pediatric dialysis patients and young adult patients with chi-
ldhood onset CKD [1]. Calciﬁcations in vascular bed
including coronary arteries and cardiac valves are signiﬁcant
risk factors for cardiovascular disease. Milliner et al. [7]
retrospectively evaluated biochemical and autopsy data of2 International Journal of Nephrology
Figure 1: Radiographies of right hand reveal calciﬁcation of radial and ulnar (arrows) arteries and their distal branches.
Figure 2: Ankle radiographies show anterior and posterior tibial arterial wall calciﬁcations (arrows).
Figure 3: Calciﬁcation of iliac arteries (arrows) is seen on pelvic radiography.International Journal of Nephrology 3
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Figure 4: Axial CT sections from diﬀerent levels show coronary artery, aorta, splenic, and iliac artery (arrows) calciﬁcations. Also note
pleural eﬀusion, ascites, and left lung collapes.
120 pediatric patients with uremia, on dialysis or following
renal transplantation in 1990. They found soft tissue calciﬁ-
cation in 72 of 120 patients (60%) and lung, myocardium,
and coronary arteries were frequent sites of calcium depo-
sition. Goodman et al. [8] suggested that calciﬁcation is
not present before the age of 20 years; however coronary
artery calciﬁcation (CAC) was detected in pediatric dialysis
patients and childhood onset chronic renal failure patients
in subsequent studies [9–12]. These vascular changes begin
as early as the ﬁrst decade of life in children on dialysis and
are also present in CKD stages 2–4 [3–6].
Prevalence of CAC was reported as 15%–20% in children
[6, 12]. In young adults with childhood-onset chronic renal
failure, CAC was found 92% [10].
Administration of large doses of vitamin D and calcium
containing phosphate binders, hypercalcemia, hyperphos-
phatemia, elevated calcium × phosphorus (Ca × P) product,
parathyroidhormone, and duration of dialysis werefound to
beassociatedwithextraosseouscalciﬁcations[3,6,8,12,13].
Plain radiography is the simplest method for the diagno-
sis of calciﬁcation, and a simple scoring system was devel-
oped for vascular calciﬁcation [14, 15]. Calciﬁed plaques
and cardiac valves can be detected by ultrasonography
and echocardiography. Both detection and quantiﬁcation of
calciﬁcation can be possible by using computed tomography
(CT), especially electron-beam CT [14]. The currently
available clinical measurements such as carotis Intima Media
ThicknessandPulseWaveVelocitywerenotsensitiveenough
to detect early calcium loading [16].
Inconclusion,becauseofhighmortalityrisk,thepatients
with vascular calciﬁcation should be followed carefully in
view of cardiovascular diseases. Better dialysis techniques,
better patient education about diet and phosphate binders,
avoidance of marked or prolonged positive calcium balance,
andcalibratingtheuseofvitaminDareimportanttoprevent
vascular calciﬁcation development.
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